Tokyo, Japan (April 25, 2013) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been enrolled in…

News

Webinar – Treatment Optimization in Locally Advanced & Metastatic Pancreatic Cancer-Tailored Patient Approach with Targeted Therapy

ByInnokeys September 29, 2020July 30, 2021

Prof. Dr. Dirk Strumberg, Oncologist in Marien Hospital Herne, Germany

News

New marketing authorization for indication newly diagnosed DIPG, recurrent/refractory DIPG, locally advanced or metastatic pancreatic cancer is approved in Chile.

ByInnokeys March 29, 2018July 30, 2021

News

Webinar – Clinical Experience of Using Nimotuzumab in Nasopharyngeal Cancer

ByInnokeys January 28, 2021July 30, 2021

Speaker: Dr. dr. Andhika Rachman, Sp.Pd-KHOM from MRCCC Siloam Hospital Indonesia

News

Webinar – How to Treat Locoregional Reccurent Disease of Nasopharyngeal Cancer

ByInnokeys November 14, 2020July 30, 2021

Speakers: 1. dr. Raymond King-Yin TSANG, MBChB, MS, FRCSEd, FRCSEd(ORL), FHKCORL, FHKAM(Otorhinolaryngology) as Head of the Division of Otorhinolaryngology of the…

Innokeys Pte Ltd is a Singapore based limited liability company that was set up to leverage the value of innovation in the field of healthcare, especially in biopharmaceuticals.

ABOUT US
THE TEAM
BUSINESS
CAREER OPPORTUNITY
CONTACT US

CONTACTS

205 Balestier Road #02-06
The Mezzo
Singapore (329682)

INNOVATIVE KEYS
TO HEALTH AND WELLBEING

HOME
ABOUT US
PRODUCTS
THE TEAM
PARTNERS
PUBLICATIONS
NEWS
CONTACT US